National Bank Financial Lowers TSO3 (TOS) Price Target to C$1.75

TSO3 (TSE:TOS) had its target price trimmed by National Bank Financial from C$2.25 to C$1.75 in a research report report published on Thursday morning. The firm currently has a sector perform rating on the stock.

A number of other analysts also recently weighed in on the company. Canaccord Genuity downgraded TSO3 from a buy rating to a speculative buy rating and cut their target price for the company from C$4.25 to C$2.75 in a research report on Friday, January 26th. Royal Bank of Canada downgraded TSO3 from an outperform rating to a sector perform rating and cut their target price for the company from C$4.25 to C$2.00 in a research report on Friday, January 26th. Scotiabank cut their target price on TSO3 from C$4.50 to C$2.75 and set an outperform rating for the company in a research report on Tuesday, January 30th. Finally, Desjardins downgraded TSO3 from a buy rating to a hold rating in a research report on Friday, January 26th. Four analysts have rated the stock with a hold rating and one has issued a buy rating to the company. The stock currently has an average rating of Hold and an average target price of C$2.12.

How to Become a New Pot Stock Millionaire

Shares of TSO3 stock opened at C$1.12 on Thursday. The firm has a market capitalization of $105.96, a price-to-earnings ratio of -10.18 and a beta of 1.11. TSO3 has a 1 year low of C$1.05 and a 1 year high of C$3.32.

ILLEGAL ACTIVITY NOTICE: “National Bank Financial Lowers TSO3 (TOS) Price Target to C$1.75” was first reported by Ticker Report and is owned by of Ticker Report. If you are reading this story on another domain, it was copied illegally and reposted in violation of US & international copyright & trademark law. The correct version of this story can be read at https://www.tickerreport.com/banking-finance/3297751/national-bank-financial-lowers-tso3-tos-price-target-to-c1-75.html.

About TSO3

TSO3 Inc is a Canada-based company engaged in the sale, production, maintenance, research, development and licensing of sterilization processes, related consumable supplies and accessories for heat-sensitive medical devices. The Company designs products for sterile processing areas in the hospital environment.

Analyst Recommendations for TSO3 (TSE:TOS)

Receive News & Ratings for TSO3 Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for TSO3 and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

American Outdoor Brands  & Sturm Ruger & Co  Financial Comparison
American Outdoor Brands & Sturm Ruger & Co Financial Comparison
DCP Midstream  and Its Competitors Head to Head Contrast
DCP Midstream and Its Competitors Head to Head Contrast
EXCO Resources  Receiving Somewhat Favorable Press Coverage, Accern Reports
EXCO Resources Receiving Somewhat Favorable Press Coverage, Accern Reports
Somewhat Positive News Coverage Somewhat Unlikely to Affect Inpixon  Stock Price
Somewhat Positive News Coverage Somewhat Unlikely to Affect Inpixon Stock Price
Biostar Pharmaceuticals  Earning Favorable Press Coverage, Report Finds
Biostar Pharmaceuticals Earning Favorable Press Coverage, Report Finds
Rigel Pharmaceuticals, Inc.  Receives $5.74 Consensus PT from Analysts
Rigel Pharmaceuticals, Inc. Receives $5.74 Consensus PT from Analysts


© 2006-2018 Ticker Report. Google+.